EGFR and cancer: To achieve this, we developed a system to couple esiRNA to the cancer cell-specific anti-EGFR-antibody cetuximab [34,35] which delivers esiRNA to the intended cancer cells, binds to the EGFR receptor and gets internalized in a receptor-dependent fashion.